JP2012514466A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012514466A5 JP2012514466A5 JP2011544926A JP2011544926A JP2012514466A5 JP 2012514466 A5 JP2012514466 A5 JP 2012514466A5 JP 2011544926 A JP2011544926 A JP 2011544926A JP 2011544926 A JP2011544926 A JP 2011544926A JP 2012514466 A5 JP2012514466 A5 JP 2012514466A5
- Authority
- JP
- Japan
- Prior art keywords
- lactalbumin
- recombinant protein
- biologically active
- active complex
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 13
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims 10
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims 10
- 102000004407 Lactalbumin Human genes 0.000 claims 9
- 108090000942 Lactalbumin Proteins 0.000 claims 9
- 235000021241 α-lactalbumin Nutrition 0.000 claims 9
- 239000012634 fragment Substances 0.000 claims 7
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims 4
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims 4
- 239000005642 Oleic acid Substances 0.000 claims 4
- 235000001014 amino acid Nutrition 0.000 claims 4
- 150000001413 amino acids Chemical class 0.000 claims 4
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 238000005342 ion exchange Methods 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 101000946384 Homo sapiens Alpha-lactalbumin Proteins 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 claims 1
- 238000005349 anion exchange Methods 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 235000018417 cysteine Nutrition 0.000 claims 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000011068 loading method Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0900260.1 | 2009-01-09 | ||
| GB0900260A GB0900260D0 (en) | 2009-01-09 | 2009-01-09 | Complex and production process |
| GB0906199.5 | 2009-04-09 | ||
| GB0906199A GB0906199D0 (en) | 2009-04-09 | 2009-04-09 | Complex and production process |
| PCT/GB2010/050024 WO2010079362A1 (en) | 2009-01-09 | 2010-01-08 | Complex and production process |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012514466A JP2012514466A (ja) | 2012-06-28 |
| JP2012514466A5 true JP2012514466A5 (enExample) | 2013-02-28 |
| JP5679992B2 JP5679992B2 (ja) | 2015-03-04 |
Family
ID=42026257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011544926A Active JP5679992B2 (ja) | 2009-01-09 | 2010-01-08 | 複合体および生産方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8796218B2 (enExample) |
| EP (1) | EP2385954B1 (enExample) |
| JP (1) | JP5679992B2 (enExample) |
| CN (1) | CN102348721A (enExample) |
| AU (1) | AU2010204178B2 (enExample) |
| CA (1) | CA2752490C (enExample) |
| DK (1) | DK2385954T3 (enExample) |
| WO (1) | WO2010079362A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5679992B2 (ja) | 2009-01-09 | 2015-03-04 | ハムレット・ファルマ・アーベー | 複合体および生産方法 |
| ES2613986T3 (es) | 2010-11-24 | 2017-05-29 | Hamlet Pharma Ab | Complejo biológicamente activo y su preparación |
| PL2882446T3 (pl) | 2012-08-09 | 2018-10-31 | Hamlet Pharma Ab | Terapia profilaktyczna i nutraceutyczna |
| CN106636157A (zh) * | 2016-09-01 | 2017-05-10 | 锦州医科大学 | 一种突变α‑乳清蛋白表达载体、制备方法及其应用 |
| GB201621752D0 (en) * | 2016-12-20 | 2017-02-01 | Hamlet Pharma Ab | Therapeutically active complexes |
| GB201707715D0 (en) * | 2017-05-14 | 2017-06-28 | Hamlet Pharma Ab | Preperation of biologically active complexes |
| US20220323391A1 (en) * | 2019-08-20 | 2022-10-13 | Hamlet Pharma Ab | Combination of a chemotherapeutic agent and alpha-lactoglubulin-oleic acid complex for cancer therapy |
| GB202015836D0 (en) | 2020-10-06 | 2020-11-18 | Hamlet Pharma Ab | Compositions |
| GB202303177D0 (en) | 2023-03-03 | 2023-04-19 | Linnane Pharma Ab | Method of predicting response to treatment |
| WO2025186107A1 (en) | 2024-03-04 | 2025-09-12 | Linnane Pharma Ab | Therapy |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7053185B1 (en) * | 1997-11-21 | 2006-05-30 | Hamlet Pharma Ab | Lactalbumin production process |
| GB9725126D0 (en) | 1997-11-27 | 1998-01-28 | Svanborg Catharina | Therapeutic agents |
| WO2001017524A1 (en) | 1999-09-09 | 2001-03-15 | Efa Sciences Llc. | Methods for treating cell proliferative disorders including cancer |
| US6639089B2 (en) | 2000-11-08 | 2003-10-28 | Soda Aromatic Co., Ltd. | Anticancer agents, perfumes or foods and drinks |
| GB0205347D0 (en) | 2002-03-07 | 2002-04-24 | Svanborg Catharina | Biologically active complex |
| GB0508880D0 (en) * | 2005-05-03 | 2005-06-08 | Hamlet Pharma Ab | Novel therapies and methods of screening for therapeutic compounds |
| US20080115228A1 (en) * | 2006-11-15 | 2008-05-15 | Yahoo! Inc. | Rights engine |
| WO2008058547A2 (en) * | 2006-11-17 | 2008-05-22 | Nya Hamlet Pharma Ab | Alpha-lactalbumin composition |
| WO2008138348A1 (en) | 2007-05-09 | 2008-11-20 | Nya Hamlet Pharma Ab | Preparation of complexed lactalbumin |
| JP5679992B2 (ja) | 2009-01-09 | 2015-03-04 | ハムレット・ファルマ・アーベー | 複合体および生産方法 |
| WO2010131237A1 (en) | 2009-05-13 | 2010-11-18 | Agriculture And Food Development Authority (Teagasc) | A process for producing a biologically active globular protein complex |
| ES2613986T3 (es) | 2010-11-24 | 2017-05-29 | Hamlet Pharma Ab | Complejo biológicamente activo y su preparación |
-
2010
- 2010-01-08 JP JP2011544926A patent/JP5679992B2/ja active Active
- 2010-01-08 CA CA2752490A patent/CA2752490C/en active Active
- 2010-01-08 US US13/143,785 patent/US8796218B2/en active Active
- 2010-01-08 CN CN2010800112651A patent/CN102348721A/zh active Pending
- 2010-01-08 DK DK10702894.6T patent/DK2385954T3/da active
- 2010-01-08 WO PCT/GB2010/050024 patent/WO2010079362A1/en not_active Ceased
- 2010-01-08 EP EP10702894A patent/EP2385954B1/en active Active
- 2010-01-08 AU AU2010204178A patent/AU2010204178B2/en active Active